Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 19;16(1):57.
doi: 10.1186/s13020-021-00467-6.

West meets east: open up a dialogue on phytomedicine

Xiuzhu Li #  1 , Weijie Chen #  1 , Jesus Simal-Gandara  2 , Milen I Georgiev  3 , Hongyi Li  1 , Hao Hu  1 , Xu Wu  4 , Thomas Efferth  5 , Shengpeng Wang  6
Affiliations
Review

West meets east: open up a dialogue on phytomedicine

Xiuzhu Li et al. Chin Med. .

Erratum in

Abstract

The desire to extend the wisdom of traditional health systems has motivated the trade of many phytomedicine on a global scale for centuries, especially some dietary herbs, making a great overlap exits between western and eastern phytomedicine. Despite the communication since ancient times, a key disconnect still exists in the dialog among western and eastern herbal researchers. There is very little systematic effort to tap into the friction and fusion of eastern and western wisdom in utilizing phytomedicine. In this review, we analyzed the similarities and differences of three representative phytomedicine, namely Rhodiola, seabuckthorn, and fenugreek, aiming to open up new horizons in developing novel health products by integrating the wisdom of the east and the west.

Keywords: Chinese medicine; Fenugreek; Phytomedicine; Rhodiola; Seabuckthorn.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Comparison of history, products, active constituents, clinical trials and patens of two Rhodiola species. A Basic information of R. crenulata and R. rosea. B Representative products developed based on R. crenulata and R. rosea. C Number of main active constituents contained in R. crenulata and R. rosea. D Advanced in clinical trials of R. crenulata and R. rosea. Data collected from PubMed (searching term of “Rhodiola” plus filter of “Clinical trial”, language limited to English) and ClinicalTrials.gov (searching term of “Rhodiola”) as of 15 June 2021. E. Patent application of R. crenulata and R. rosea. Data collected from the Lens (www.lens.org, Searching term: Rhodiola) as of 15 June 2021
Fig. 2
Fig. 2
Plant morphology, representative products, and clinical studies of sea buckthorn. A Plant morphology of Hippophae rhamnoides L. (Sea buckthorn). B Chemical structure of two most common omega-7 fatty acids in sea buckthorn, namely palmitoleic acid and vaccenic acid. C Representative products developed based on sea buckthorn from western countries. D Representative products developed based on sea buckthorn from eastern countries. E A summarize of clinical trials of Sea buckthorn. Data collected from PubMed (searching term of “Hippophae rhamnoides” or “sea buckthorn” plus filter of “Clinical trial”, language limited to English) and ClinicalTrials.com (searching term of “Hippophae rhamnoides” or “sea buckthorn”) as of 15 June 2021
Fig. 3
Fig. 3
Plant morphology, geographical distribution, products, and clinical studies of fenugreek. A Plant morphology of Trigonella foenum-graecum L. (Fenugreek). B Geographical distribution of fenugreek. C Representative products developed based on fenugreek from western countries. D Representative products developed based on fenugreek from eastern countries. E Clinical trials of Sea buckthorn. Data collected from PubMed and ClinicalTrials.com as of June 2021 (Pubmed: searching term of “Trigonella foenum-graecum” or “fenugreek” plus filter of “Clinical trial”, language limited to English); ClinicalTrials.gov: searching term of “Trigonella foenum-graecum” or “fenugreek”)
See this image and copyright information in PMC

References

    1. Sorkin BC, Kuszak AJ, Bloss G, Fukagawa NK, Hoffman FA, Jafari M, Barrett B, Brown PN, Bushman FD, Casper SJ, Chilton FH, Coffey CS, Ferruzzi MG, Hopp DC, Kiely M, Lakens D, MacMillan JB, Meltzer DO, Pahor M, Paul J, Pritchett-Corning K, Quinney SK, Rehermann B, Setchell KDR, Sipes NS, Stephens JM, Taylor DL, Tiriac H, Walters MA, Xi D, Zappala G, Pauli GF. Improving natural product research translation: from source to clinical trial. FASEB J. 2020;34:41–65. - PMC - PubMed
    1. Quave CL, Pardo-de-Santayana M, Pieroni A. Medical ethnobotany in Europe: from field ethnography to a more culturally sensitive evidence-based CAM? Evid Based Complement Alternat Med. 2012;2012:156846. - PMC - PubMed
    1. Tabajara de Oliveira Martins D, Rodrigues E, Casu L, Benitez G, Leonti M. The historical development of pharmacopoeias and the inclusion of exotic herbal drugs with a focus on Europe and Brazil. J Ethnopharmacol. 2019;240:111891. - PubMed
    1. Booker A, Zhai L, Gkouva C, Li S, Heinrich M. From traditional resource to global commodities: a comparison of rhodiola species using NMR spectroscopy-metabolomics and HPTLC. Front Pharmacol. 2016;7:254. - PMC - PubMed
    1. Cui JL, Guo TT, Ren ZX, Zhang NS, Wang ML. Diversity and antioxidant activity of culturable endophytic fungi from alpine plants of Rhodiola crenulata, R. angusta, and R. sachalinensis. PLoS ONE. 2015;10:e0118204. - PMC - PubMed

LinkOut - more resources